The ACAA-insertion/deletion polymorphism at the 3′ UTR of the IGF-II receptor gene is associated with type 2 diabetes and surrogate markers of insulin resistance

European Journal of Endocrinology

Volumn 155, Issue 2, 2006, Pages 331-336

  Villuendas, Gemma ^a   Botella Carretero, José I ^a   López Bermejo, Abel ^b   Gubern, Carme ^b   Ricart, Wifredo ^b   Fernández Real, José Manuel ^b   San Millán, José L ^a   Escobar Morreale, Héctor F ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; ANTIHYPERTENSIVE AGENT; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LIPID; ORAL ANTIDIABETIC AGENT; SOMATOMEDIN B RECEPTOR; TRIACYLGLYCEROL;

3' UNTRANSLATED REGION; ADULT; ALLELE; ANTHROPOMETRY; ARTICLE; CHROMOSOME 6Q; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE INSERTION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SPAIN; TRIACYLGLYCEROL BLOOD LEVEL; WILD TYPE;

3' UNTRANSLATED REGIONS; ADULT; AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENE DELETION; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTOR, IGF TYPE 2;

EID: 33747639223     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02217     Document Type: Article

References (28)

1. van Haeften TW & Twickler TB. Insulin-like growth factors and pancreas beta cells. European Journal of Clinical Investigation 2004 34 249-255.
2. Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB & Wareham NJ. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 2002 359 1740-1745.
3. Nakae J, Kido Y & Accili D. Distinct and overlapping functions of insulin and IGF-I receptors. Endocrine Reviews 2001 22 818-835.
4. 't Hart LM, Fritsche A, Rietveld I, Dekker JM, Nijpels G, Machicao F, Stumvoll M, van Duijn CM, Haring HU, Heine RJ, Maassen JA & van Haeften TW. Genetic factors and insulin secretion: gene variants in the IGF genes. Diabetes 2004 53 S26-S30.
5. Laukkanen O, Pihlajamaki J, Lindstrom J, Eriksson J, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Tuomilehto J, Uusitupa M & Laakso M. Common polymorphisms in the genes regulating the early insulin signalling pathway: effects on weight change and the conversion from impaired glucose tolerance to Type 2 diabetes. The finnish diabetes prevention study. Diabetologia 2004 47 871-877.
6. Devedjian JC, George M, Casellas A, Pujol A, Visa J, Pelegrin M, Gros L & Bosch F. Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes. Journal of Clinical Investigation 2000 105 731-740.
7. Serradas P, Goya L, Lacorne M, Gangnerau MN, Ramos S, Alvarez C. Pascual-Leone AM & Portha B. Fetal insulin-like growth factor-2 production is impaired in the GK rat model of type 2 diabetes. Diabetes 2002 51 392-397.
8. Gaunt TR, Cooper JA, Miller GJ, Day IN & O'Dell SD. Positive associations between single nucleotide polymorphisms in the IGF2 gene region and body mass index in adult males. Human Molecular Genetics 2001 10 1491-1501.
9. San Millan JL, Corton M, Villuendas G, Sancho J, Peral B & Escobar-Morreale HF. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. Journal of Clinical Endocrinology and Metabolism 2004 89 2640-2646.
10. Di Bacco A & Gill G. The secreted glycoprotein CREG inhibits cell growth dependent on the 5 mannose-6-phosphate/insulin-like growth factor II receptor. Oncogene 2003 22 5436-5445.
11. Ikushima H, Munakata Y, Ishii T, Iwata S, Terashima M, Tanaka H, Schlossman SF & Morimoto C. Internalization of CD26 by marmose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation. PNAS 2000 97 8439-8444.
12. Laureys G, Barton DE, Ullrich A & Francke U. Chromosomal mapping of the gene for the type II insulin-tike growth factor receptor/ cation-independent mannose 6-phosphate receptor in man and mouse. Genomics 1988 3 224-229.
13. Riesewijk AM, Xu YQ, Schepens MT, Mariman EM, Polychronakos C, Ropers HH & Kalscheuer VM. Absence of an obvious molecular imprinting mechanism in a human fetus with monoallefic IGF2R expression. Biochemical and Biophysical Research Communications 1998 245 272-277.
14. Duggirala R, Blangero J, Almasy L, Arya R, Dyer TD, Williams KL, Leach RJ, O'Connell P & Stern MP. A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in nondiabetic Mexican Americans. American Journal of Human Genetics 2001 68 1149-1164.
15. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005 28 S37-S42.
16. Fernandez-Real JM, Gutierrez C, Ricart W, Castineira MJ, Vendrell J & Richart C. Plasma levels of the soluble fraction of tumor necrosis factor receptors 1 and 2 are independent determinants of plasma cholesterol and LDL-cholesterol concentrations in healthy subjects. Atherosclerosis 1999 146 321-327.
17. Smrzka OW, Fae I, Stoger R, Kurzbauer R, Fischer GF, Henn T, Weith A & Barlow DP. Conservation of a maternal-specific methylation signal at the human IGF2R locus. Human Molecular Genetics 1995 4 1945-1952.
18. Lemeshow S, Hosmer DW, Klar J & Lwanga SK. Adequacy of sample size in health studies. Chichester, UK: World Health Organization, Wiley, 1990.
19. Cohen J. Statistical power analysis for the behavioral sciences. 2nd edn. Hillsdale, NJ: Lawrence Erlbaum, 1988.
20. Harris MI, Eastman RC, Cowie CC, Flegal KM & Eberhardt MS. Comparison of diabetes diagnostic categories in the US population according to the American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria. Diabetes Care 1997 20 1859-1862.
21. Sleat DE, Chen TL, Raska K, Jr & Lobel F. Increased levels of glycoproteins containing 10 mannose 6-phosphate in human breast carcinomas. Cancer Research 1995 55 3424-3430.
22. Killian JK & Jirtle RL. Genomic structure of the human M6P/IGF2 receptor. Mammalian Genome 1999 10 74-77.
23. Ludwig T, Eggenschwiler J, Fisher P, D'Ercole AJ, Davenport ML & Efstratiadis A. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in IGF2 and IGF1R null backgrounds. Developmental Biology 1996 177 517-535.
24. Morison IM, Becroft DM, Taniguchi T, Woods CG & Reeve AE. Somatic overgrowth associated with overexpression of insulin-like growth factor II. Nature Medicine 1996 2 311-316.
25. Xie S & Kang JX. Differential expression of the mannose 6-phosphate/ insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential. Medical Science Monitor 2002 8 BR293-300.
26. Ong KK & Dunger DB. Developmental aspects in the pathogenesis of type 2 diabetes. Molecular and Cellular Endocrinology 2001 185 145-149.
27. McCann JA, Xu YQ, Frechette R, Guazzarotti L & Polychronakos C. The insulin-like growth factor-II receptor gene is associated with type 1 diabetes: evidence of a maternal effect. Journal of Clinical Endocrinology and Metabolism 2004 89 5700-5706.
28. Tarrago D, Aguilera I, Melero J, Wichmann I, Nunez-Roldan A & Sanchez B. Identification of cation-independent mannose 6-phosphate receptor/ insulin-like growth factor type-2 receptor as a novel target of autoantibodies. Immunology 1999 98 652-662.